Abstract
Mild Cognitive Impairment in Parkinson's Disease (PD-MCI) is common and may be associated with accelerated progression to dementia. Considering the importance of this emerging entity, new diagnostic criteria have recently been proposed. Early recognition and accurate classification of PD-MCI could offer opportunities for novel therapeutic interventions. This review discusses current definitions for PD-MCI, the screening tools used, the pattern of cognitive deficits observed, and the predictors of cognitive decline and transition to Parkinson's Disease Dementia. Emerging biomarkers, which may aid diagnosis, are also explored and the role of novel treatment options is considered.
| Original language | English |
|---|---|
| Article number | 576091 |
| Pages (from-to) | 1-8 |
| Number of pages | 8 |
| Journal | Neurology Research International |
| Volume | 2013 |
| DOIs | |
| Publication status | Published - 2013 |
| Externally published | Yes |